Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
about
RYR2 sequencing reveals novel missense mutations in a Kazakh idiopathic ventricular tachycardia study cohortMutations in calmodulin cause ventricular tachycardia and sudden cardiac deathCalsequestrin 2 and arrhythmiasCPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activityRole of Cytosolic Calcium Diffusion in Murine Cardiac Purkinje CellsTherapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug DiscoveryNext-Generation Sequencing in Post-mortem Genetic Testing of Young Sudden Cardiac Death CasesCatecholaminergic polymorphic ventricular tachycardia: An exciting new eraGenetics of inherited primary arrhythmia disordersInduced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmiasThe molecular autopsy: should the evaluation continue after the funeral?Mechanisms of sudden cardiac deathOptimal antiarrhythmic drug therapy for electrical stormDisease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interfaceCardiac disease and arrhythmogenesis: Mechanistic insights from mouse modelsPatient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular TachycardiaInherited ion channel diseases: a brief reviewRecent advances in genetic testing and counseling for inherited arrhythmiasCurrent topics in catecholaminergic polymorphic ventricular tachycardia2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theCalsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardiaInherited conduction system abnormalities--one group of diseases, many genesGenetic bases of arrhythmogenic right ventricular CardiomyopathyCalsequestrin mutations and catecholaminergic polymorphic ventricular tachycardiaThe RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading framRyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR)Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesisThree-dimensional reconstruction of the recombinant type 2 ryanodine receptor and localization of its divergent region 1Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardiaDynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptorArrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.The new kids on the block of arrhythmogenic disorders: Short QT Syndrome and early repolarization.Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside.Modulation of CaV1.2 channels by Mg2+ acting at an EF-hand motif in the COOH-terminal domainLeaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice.Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia.A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy.
P2860
Q21131998-DE3AFF5A-BBE2-4239-91E2-EE27977CDEC1Q24300356-7290F113-86EA-46C5-AF7E-904CEECF88F3Q24300626-5C8A2152-FB1F-472F-A198-EE5497E79A3EQ24567695-97972748-429D-4A18-92C5-2A659C9701A2Q26740389-CF4D754B-1D74-4231-8954-25DA7C562F70Q26744730-4C8A1AFC-641E-42F5-86CC-87F4E033F3ACQ26745883-17FEC328-6EA0-4892-82DA-A083D9817DF3Q26747056-6A4CC35B-D547-4F56-9555-C68A0E563572Q26783570-05FC8A7C-F55A-44BA-825C-90FACCAF183BQ26853227-9F2BE27B-48C0-49E3-84BA-7EC277AC9EE5Q26864392-0D4881B5-ED5A-4F1D-BE5E-F191DDA02E93Q27011791-8686F5B9-4463-466A-8C0D-36FB4A926B08Q27027096-A7FA27BE-45F3-44B7-842E-C66B992DB8EEQ27676474-F520DA5F-054B-43E2-8A81-9DAC4D100F1AQ28066019-49632BB6-AF70-45EE-84AC-56D75B604CA3Q28067569-A403DDAB-1194-4093-8EA5-04C3FF357741Q28071914-62D21337-CA93-4C34-BD2F-35B3EF203D12Q28074154-E5DC56F5-3D87-41F2-9C22-B5DDC2B68D81Q28076784-B8AF2524-9227-4F67-9ACB-37A7EDDF9A34Q28087002-3B974896-30D3-4DB5-9FE1-E5307FAEA814Q28235110-61CB1617-08BB-4136-BBDE-ABFF68AD13FCQ28236888-473E0B20-AFE4-4C59-A0B4-AB5DE6993F46Q28249805-F1CE830A-732C-40A5-B521-17EA944F0B5DQ28262015-47286A5B-CCEE-42A8-B660-E767E1DB0C0BQ28265202-BC9A93DF-8B68-4C6A-99F4-0FADEDDAF6FFQ28278038-8C84727F-D033-4627-8F62-FDB3EBC6F493Q28308142-854AF5E3-C443-4A21-965D-4A95E825188FQ28505252-DDD1B18D-75F5-45BC-9CAC-1C3BBC8AA173Q28589230-7D7089F9-DE4D-4E1E-85B0-A8F21D0C2EFFQ28589538-06E4F306-7498-4972-8C92-CD2AE24059AAQ28595062-79D0D760-4EE2-4667-8CF1-4E55F63C6CE5Q30234301-D48DE627-6EE7-41E0-B7C3-2EDDB76AC788Q30378666-F1CA7047-76EC-467A-A599-71A9AC0E5B4DQ30443351-EF4572E9-F0EF-464B-8E81-894289A90392Q30481900-1783E262-2E1E-48F0-9422-7CCB54509AFBQ30498471-AB2BD439-8876-4883-BF41-9A10FAD5B3E9Q30557177-8922009A-6C89-437C-9167-1745947FCC84Q33151464-15D3BB33-37A6-4711-93A1-D8EADF6988C5Q33151465-25404DC4-F234-4C17-9EAC-95C83B01B48FQ33153519-DDFB13FF-1CA3-4186-9716-BB68578E1978
P2860
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Clinical and molecular charact ...... rphic ventricular tachycardia.
@ast
Clinical and molecular charact ...... rphic ventricular tachycardia.
@en
type
label
Clinical and molecular charact ...... rphic ventricular tachycardia.
@ast
Clinical and molecular charact ...... rphic ventricular tachycardia.
@en
prefLabel
Clinical and molecular charact ...... rphic ventricular tachycardia.
@ast
Clinical and molecular charact ...... rphic ventricular tachycardia.
@en
P2093
P50
P1433
P1476
Clinical and molecular charact ...... orphic ventricular tachycardia
@en
P2093
Abraham Benatar
Angelica DeLogu
Fernando Coltorti
Fernando E S Cruz Filho
Gabriele Vignati
Luciano DeSimone
Maurizio Gasparini
Mirella Memmi
Raffaella Bloise
Roberto Keegan
P356
10.1161/01.CIR.0000020013.73106.D8
P407
P577
2002-07-01T00:00:00Z